NCT02861664 - Assessment of the Efficacy of an Experimental Occlusion Technology Dentifrice in Dentinal Hypersensitivity | Biotech Hunter

Enrollment

135

Participants

Timeline

Start Date

September 21, 2016

Primary Completion Date

December 1, 2016

Study Completion Date

December 24, 2016

Conditions

Dentin Sensitivity

Interventions

OTHER

Stannous fluoride (SnF2)

Dentifrice containing 0.454% weight by weight (w/w) SnF2 and 0.072% w/w NaF

OTHER

Sodium monofluorophosphate (SMFP)

Dentifrice containing 1400 ppm fluoride as SMFP

Trial Locations (1)

GSK Investigational Site, Wuhan